Back to Search
TERENCE O'HARE, M.D.
M.D.
Plastic and Reconstructive Surgery Physician
NPI: 1891943478Individual
Specialties, Licenses & Credentials
Plastic and Reconstructive Surgery PhysicianPrimary
Surgery — Plastic and Reconstructive Surgery
Code: 2086S0122X
036104044(IL)
Research & Publications (20)
Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients.
PMID 12723846·Community Ment Health J·2003
4-observational
Co-occurring psychosocial distress and substance abuse in community clients: initial validity and reliability of self-report measures.
PMID 11504141·Community Ment Health J·2001
8-other
The Drinking Context Scale. A confirmatory factor analysis.
PMID 11306215·J Subst Abuse Treat·2001
8-other
Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.
PMID 19340004·Leukemia·2009
8-other
RNAi screen for rapid therapeutic target identification in leukemia patients.
PMID 19433805·Proc Natl Acad Sci U S A·2009
8-other
Single particle quantum dot imaging achieves ultrasensitive detection capabilities for Western immunoblot analysis.
PMID 19453141·ACS Nano·2009
8-other
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check.
PMID 18491988·Expert Opin Investig Drugs·2008
6-review
Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
PMID 18559973·Blood·2008
7-preclinical
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemia.
PMID 18577744·J Natl Cancer Inst·2008
8-other
Growth arrest of BCR-ABL positive cells with a sequence-specific polyamide-chlorambucil conjugate.
PMID 18974832·PLoS One·2008
7-preclinical
Epithiospecifier protein activity in broccoli: the link between terminal alkenyl glucosinolates and sulphoraphane nitrile.
PMID 18977005·Phytochemistry·2008
8-other
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib.
PMID 18367669·Proc Natl Acad Sci U S A·2008
8-other
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?
PMID 19254881·Clin Lymphoma Myeloma·2008
6-review
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
PMID 18025156·Blood·2008
8-other
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.
PMID 17496200·Blood·2007
7-preclinical
Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemia.
PMID 17382021·Clin Lymphoma Myeloma·2007
6-review
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
PMID 16880519·Mol Cell Biol·2006
7-preclinical
Activating alleles of JAK3 in acute megakaryoblastic leukemia.
PMID 16843266·Cancer Cell·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 676 N MICHIGAN AVE, SUITE 3850
CHICAGO, IL 60611 - Phone
- (312) 642-4481
Quick Facts
- NPI
- 1891943478
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile